CClinicalTrials.gg
RecruitingNCT04142606FETUSUpdated Nov 20, 2025

LUMIERE on the FETUS

An observational study in Pregnancy, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-20.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

From the registry’s dates

  • Started Dec 2019; still recruiting 6 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,500
Ages
18 Years and older
Sex
Female
01

Study summary

Congenital anomalies are a major public health problem. They affect 2-3% of births, around 20,000 new cases per year in France, of which 15% are cared for in Ile de France. These congenital anomalies are a major cause of morbidity, infant mortality and disability. They are also a major cause of death during the infant period (22% of deaths during the first year of life: source CépiDC Inserm 2010). The detection, accurate diagnosis and accurate prognosis, particularly functional, of these congenital anomalies are still difficult in the current monitoring of pregnancy, which is based primarily on ultrasound. The use and development of modern imaging techniques is now essential to enable doctors to better see and better examine the fetus. Alongside ultrasound, Magnetic Resonance Imaging (MRI) is a technique that has undergone significant development in recent years. MRI must allow the effective anatomical and functional evaluation of the main fetal organs and could in particular be interesting in several situations in which it has not yet been sufficiently evaluated and is not yet performed in clinical routine.

Read the detailed description

The inclusion will take place from 16WF to 36WG, within the framework of one of the 4 clinical subgroups of patients envisaged.

The standardized anatomic and functional MRI examination will in all cases last less than 45 minutes and will be based on sequences already used in clinical practice.

Clinical, biological, and ultrasound data will be collected prospectively and used for the usual management of the patient. For the purposes of the study, these data will be secondarily anonymized and analyzed in connection with the MRI data and the perinatal outcome to meet the specific objectives.

The lost-to-follow-up bias will be limited by the simplicity of the proposed perinatal surveillance, which does not differ from the surveillance usually recommended for these pregnancies

02

Conditions studied

  • Pregnancy
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant patients followed in the Fetal Medicine Department of the Necker-Enfants Malades hospital belonging to one of the following 4 groups:

  • Having prenatal ultrasound screening without detected abnormality
  • Having an ultrasound examination without abnormality detected but in whom ultrasound examination is not optimal (poor technical conditions, multiple pregnancies, obese patients)
  • Standardized prenatal screening with ultrasound examination finding an isolated anomaly that does not currently constitute a commonly accepted indication of fetal MRI
  • A medical termination of pregnancy, in addition to a fetopathological examination (virtopsy)

Inclusion criteria

  • patient ≥ 18 years
  • Single or twin pregnancy
  • gestational age≥ 16 WG and ≤ 36 WG based on cranio-caudal length (LCC) dating
  • Collection of the patient's consent

Exclusion criteria

Exclusion Criteria:

contraindication to MRI

  • multiple pregnancies > 2
  • subsequent follow-up impossible
  • maternal condition contraindicates continuation of pregnancy
  • patient having to have an MRI examination as part of the normal clinical follow-up of her pregnancy (identified or strongly suspected echocardiographic abnormality on ultrasound, diaphragmatic dome hernia, CMV fetal infection, antecedent brain abnormality in siblings, STT operated)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Control Group (Group 1)

    Having prenatal ultrasound screening without detected abnormality

    Other: fetal MRI

  • Non Optimal Ultrasound Scan Group (Group 2)

    Having an ultrasound examination without abnormality detected but in whom ultrasound examination is not optimal (poor technical conditions, multiple pregnancies, obese patients)

    Other: fetal MRI

  • Malformation Group (Group 3)

    Standardized prenatal screening with ultrasound examination finding an isolated anomaly that does not currently constitute a commonly accepted indication of fetal MRI

    Other: fetal MRI

  • TOP Group (Group 4)

    A medical termination of pregnancy, (TOP), in addition to a fetopathological examination (virtopsy)

    Other: fetal MRI

Interventions

  • Otherfetal MRI

    The MRI examination added by this research, without injection or sedation, induces no risk for the mother as for the fetus (s)

06

What researchers measure

Primary outcomes

  1. feasibility of advanced MRI techniques

    % of satisfactory sequences

    Time frame: From inclusion to end of neonatal period (max 25 weeks)

  2. feasibility of advanced MRI techniques

    quality of standardized morphological fetal examination using recognizable criteria of normality

    Time frame: From inclusion to end of neonatal period (max 25 weeks)

  3. feasibility of advanced MRI techniques

    quality of standardized functional fetal examination using recognizable criteria of normality

    Time frame: From inclusion to end of neonatal period (max 25 weeks)

Secondary outcomes

  1. concordance of information collected by MRI

    Concordance of the diagnosis carried out on each standardized section in ultrasound, MRI and the final diagnosis: Standardized cuts with main anatomical landmarks seen and of usual appearance.

    Time frame: From inclusion to end of neonatal period (max 25 weeks)

  2. concordance of information collected by MRI

    Concordance of the diagnosis carried out on each standardized section in ultrasound, MRI and the final diagnosis: Standardized cuts with main anatomical landmarks seen and unusual appearance.

    Time frame: From inclusion to end of neonatal period (max 25 weeks)

  3. Concordance of information collected by MRI

    Concordance of the diagnosis carried out on each standardized section in ultrasound, MRI and the final diagnosis: Standardized cuts with main non-evaluable anatomical landmarks.

    Time frame: From inclusion to end of neonatal period (max 25 weeks)

  4. Acceptability of the examination for the patient: leackertLikert scale

    will be assessed by a Likert scale. which is a psychometric tool for measuring an attitude in individuals. It consists of one or more statements (statements or items) for which the respondent expresses her degree of agreement or disagreement (5 items from 1 to 5 points : from "very poor", "poor", "average", "good", "very good"). A scale of several items can be summarized by the average of the item scores.

    Time frame: Through MRI study completion an average of 6 months

  5. Reproducibility of the examination analysis

    will be assessed by means of Kappa coefficient

    Time frame: After study completion, an average of one year

  6. relevance of MRI

    will be assessed by the % of added informations

    Time frame: From inclusion to end of neonatal period (max 25 weeks)

  7. Specific Absorption Rate for each type of sequence

    SAR is an MRI machine parameter

    Time frame: After study completion, an average of one year

  8. feasibility of fusion imaging (echo / MRI)

    will be assessed by the success rate of appropriate matching - % of successful echo-IRM fusion

    Time frame: After study completion, an average of one year

  9. norms of growth of main organs and placenta

    Creating of normal curves by MRI measurements for length at various gestational ages

    Time frame: After study completion, an average of one year

  10. norms of growth of main organs and placenta

    Creating of normal curves by MRI measurements: for width at various gestational ages

    Time frame: After study completion, an average of one year

  11. norms of growth of main organs and placenta

    Creating of normal curves by MRI measurements for height at various gestational ages

    Time frame: After study completion, an average of one year

  12. norms of growth of main organs and placenta

    Creating of normal curves by MRI measurements for volumes at various gestational ages

    Time frame: After study completion, an average of one year

  13. Establishment of an anatomical and functional database on a large group of healthy fetuses

    Build up of normal atlas of MRI images in normal fetuses. We will stored anonymous images of fetal brain acquired thought gestation and anatomical and using functionnal sequences

    Time frame: After study completion, an average of one year

  14. Establishment of an anatomical and functional database on a large group of healthy fetuses

    Build up of normal atlas of MRI images in normal fetuses. We will stored anonymous images of fetal thorax acquired thought gestation and anatomical and using functionnal sequences

    Time frame: After study completion, an average of one year

  15. Establishment of an anatomical and functional database on a large group of healthy fetuses

    Build up of normal atlas of MRI images in normal fetuses. We will stored anonymous images of fetal heart acquired thought gestation and anatomical and using functionnal sequences

    Time frame: After study completion, an average of one year

  16. Establishment of an anatomical and functional database on a large group of healthy fetuses

    Build up of normal atlas of MRI images in normal fetuses. We will stored anonymous images of fetal abdomen acquired thought gestation and anatomical and using functionnal sequences

    Time frame: After study completion, an average of one year

  17. Establishment of an anatomical and functional database on a large group of healthy fetuses

    Build up of normal atlas of MRI images in normal fetuses. We will stored anonymous images of fetal limb acquired thought gestation and anatomical and using functionnal sequences

    Time frame: After study completion, an average of one year

  18. Establishment of an anatomical and functional database on a large group of healthy fetuses

    Build up of normal atlas of MRI images in normal fetuses. We will stored anonymous images of placenta acquired thought gestation and anatomical and using functionnal sequences

    Time frame: After study completion, an average of one year

  19. Concordance of diagnosis

    Concordance of diagnosis between virtual autopsy and foetopathology

    Time frame: Termination of pregnancy (max 25 weeks)

07

Study locations

1 of 1 sites recruiting
  • Necker - Enfants Malades Hospital
    Paris, 75015, France
    Recruiting
08

References and documents

Publications

  • Bouachba A, Chabourlin J, Grevent D, Neves JJ, Bussieres L, Vaillant S, Salomon LJ, Gorincour G. Normative range for MRI amniotic fluid volume from 16 to 36 gestational weeks: Absolute and relative values, and correlation to ultrasound. Acta Obstet Gynecol Scand. 2026 May;105(5):878-886. doi: 10.1111/aogs.70153. Epub 2026 Apr 8. PubMed 41949001 ↗
  • Bouachba A, Bartin R, De Jesus Neves J, Bussieres L, Grevent D, Virfollet J, Gauchard G, Bobet L, Roux N, Glemain B, Salomon LJ, Gorincour G. Normative range of MRI-based fetal body volume and association with ultrasonographically estimated fetal weight at 16-36 weeks: prospective study. Ultrasound Obstet Gynecol. 2025 Jul;66(1):81-88. doi: 10.1002/uog.29234. Epub 2025 May 26. PubMed 40418192 ↗
  • Bartin R, Melbourne A, Bobet L, Gauchard G, Menneglier A, Grevent D, Bussieres L, Siauve N, Salomon LJ. Static and dynamic responses to hyperoxia of normal placenta across gestation with T2*-weighted MRI sequences. Ultrasound Obstet Gynecol. 2024 Aug;64(2):236-244. doi: 10.1002/uog.27609. PubMed 38348601 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04142606
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
LUMIERE Fondation ( fondation-lumiere.org) under the aegis of Fondation de France, University of Paris 5 - Rene Descartes, URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Oct 29, 2019
Start date
Dec 6, 2019
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Nov 20, 2025

Study contacts

David Grevent, MD PHD
Contact
david.grevent@gmail.com
+ 33144841734
Aminata TRAORE
Contact
aminata.traore6@aphp.fr
+ 331 48 19 27 34
Laurent Salomon, MD, PhD
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion